What is the recommended post‑exposure rabies vaccination schedule (days of dosing) for an unvaccinated adult, including rabies‑immune globulin administration and any adjustments for immunocompetent versus immunocompromised patients or those with prior pre‑exposure vaccination?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rabies Post-Exposure Prophylaxis Vaccination Schedule

For previously unvaccinated immunocompetent adults, administer 4 doses of rabies vaccine (HDCV or PCECV) intramuscularly on days 0,3,7, and 14, combined with rabies immune globulin (HRIG) 20 IU/kg infiltrated into and around the wound on day 0. 1, 2, 3

Standard Regimen for Unvaccinated Immunocompetent Patients

Vaccine Schedule

  • Administer 1.0 mL of HDCV or PCECV intramuscularly on days 0,3,7, and 14 (day 0 is the day the first dose is given, not the day of exposure). 1, 3
  • Inject into the deltoid muscle for adults and older children; the anterolateral thigh is acceptable for infants and young children. 1, 3
  • Never administer vaccine in the gluteal area, as this results in inadequate immune response and vaccine failure. 1, 3, 4

Rabies Immune Globulin (HRIG)

  • Give HRIG once only on day 0 at a dose of 20 IU/kg body weight. 1, 2, 3
  • Infiltrate as much HRIG as anatomically feasible around and into the wound(s); inject any remaining volume intramuscularly at a site distant from the vaccine injection site. 1, 2
  • If HRIG was not given on day 0, it can still be administered up to and including day 7 of the vaccine series; beyond day 7, HRIG should not be given because vaccine-induced antibodies are presumed to have developed. 1, 3
  • Never administer HRIG in the same syringe or at the same anatomical site as the vaccine, as this can interfere with vaccine efficacy. 1, 3
  • Never exceed the 20 IU/kg dose, as higher doses suppress active antibody production. 1, 2, 3

Essential Wound Care

  • Immediately wash all wounds thoroughly with soap and water for 15 minutes before any other intervention—this is the single most effective measure for preventing rabies. 5, 2, 3
  • Irrigate wounds with a virucidal agent such as povidone-iodine solution if available. 5, 2

Modified Regimens for Special Populations

Previously Vaccinated Persons

  • Administer only 2 doses of vaccine (1.0 mL each) on days 0 and 3. 1, 2, 3
  • Do NOT give HRIG to previously vaccinated persons, as it will suppress the anamnestic immune response. 1, 2, 3
  • "Previously vaccinated" means completion of a full pre-exposure or post-exposure prophylaxis series with cell-culture vaccine, or documented adequate rabies virus-neutralizing antibody response. 1

Immunocompromised Patients

  • Administer a 5-dose vaccine regimen on days 0,3,7,14, and 28 plus HRIG 20 IU/kg on day 0. 1, 5, 2, 3
  • Perform serologic testing 7-14 days after the final dose to confirm adequate antibody response (≥0.5 IU/mL by RFFIT). 5, 3
  • This 5-dose regimen applies even to immunocompromised patients who were previously vaccinated. 3

Schedule Adherence and Missed Doses

Timing Flexibility

  • Initiate post-exposure prophylaxis as soon as possible after exposure, ideally within 24 hours, though there is no absolute cutoff beyond which treatment should be withheld. 2
  • Delays of a few days for individual doses are unimportant and do not compromise protection. 1, 3
  • If a dose is missed, administer it immediately when the patient presents and resume the schedule maintaining the same intervals between doses. 1, 3
  • For example, if the day 7 dose is missed and the patient presents on day 10, give that dose on day 10 and administer the remaining dose on day 17 (maintaining the 7-day interval). 1

When Serologic Testing Is Indicated

  • Routine post-vaccination antibody testing is not necessary for healthy immunocompetent patients completing the 4-dose regimen, as 100% demonstrate adequate antibody response. 1, 3
  • Consider serologic testing when substantial deviations from the schedule occur, for immunocompromised patients, or when there are concerns about vaccine potency or administration technique. 1, 3

Critical Pitfalls to Avoid

  • Never use the gluteal area for vaccine administration—this is associated with vaccine failure. 1, 3, 4
  • Never exceed 20 IU/kg of HRIG—higher doses suppress active antibody production. 1, 2, 3
  • Never give HRIG and vaccine in the same syringe or anatomical site. 1, 3
  • Never give HRIG to previously vaccinated immunocompetent persons—this critically impairs the memory immune response. 1, 2, 3
  • Do not delay wound cleaning—it is the most crucial first step. 5, 2, 3

Efficacy

  • When administered promptly and appropriately, this post-exposure prophylaxis regimen combining wound care, HRIG infiltration, and the vaccine series is nearly 100% effective in preventing human rabies. 2
  • The 4-dose regimen produces adequate antibody response in all healthy persons, with 100% seroprotection maintained through day 180. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Rabies Post-Exposure Prophylaxis Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rabies Post-Exposure Prophylaxis Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Post-Exposure Prophylaxis for Rabies in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Are the first 4 doses of the intramuscular (IM) rabies vaccine regimen necessary for an immunocompetent patient after a dog bite?
What is the recommended course of action for a 27-year-old female patient who presents for her second rabies vaccine dose on day 3 after being scratched by a stray cat and experiencing mild symptoms after the first dose?
What is the recommended treatment for a patient with a history of a category 3 bite, previously treated with intramuscular (IM) rabies vaccine and rabies immunoglobulin (RIG), who completed the first 4 doses of the post-exposure prophylaxis (PEP) series but missed the 5th dose on day 28?
What is the recommended route of administration for the antirabies (rabies) vaccine in adults, children, and infants?
Is a 5th dose of rabies vaccine on day 28 necessary for a previously partially vaccinated patient with potential new rabies exposure, considering their immunocompromised status?
Is there any drug interaction between Concerta (methylphenidate) and valacyclovir?
In a patient with coronary artery disease who has undergone percutaneous coronary intervention and now presents with a Wenckebach (Mobitz type I) AV block, what additional reversible or ischemic causes should be evaluated?
What is the prognosis for a patient with non‑Hodgkin lymphoma and a lactate dehydrogenase level of 550 U/L?
What is the recommended next step in managing a patient with chronic hyperuricemia >520 µmol/L despite taking febuxostat 80 mg tablets at 1½ tablets daily (total 120 mg)?
In a cirrhotic patient with portal hypertension after successful rubber‑band ligation of esophageal varices, is carvedilol appropriate for secondary prophylaxis, and what starting dose, titration schedule, contraindications, and monitoring are recommended?
What are the primary and secondary causes of thrombocytosis and what is the recommended diagnostic work‑up?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.